Elanco Animal Health Inc (ELAN)
16.88
-0.32
(-1.89%)
USD |
NYSE |
May 10, 14:28
Elanco Animal Health Profit Margin (Quarterly): 2.66% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.66% |
| December 31, 2023 | -13.62% |
| September 30, 2023 | -102.6% |
| June 30, 2023 | -9.18% |
| March 31, 2023 | 8.19% |
| December 31, 2022 | -5.48% |
| September 30, 2022 | -6.34% |
| June 30, 2022 | -0.85% |
| March 31, 2022 | 4.16% |
| December 31, 2021 | -9.71% |
| September 30, 2021 | -9.20% |
| June 30, 2021 | -16.42% |
| March 31, 2021 | -4.91% |
| December 31, 2020 | -29.64% |
| Date | Value |
|---|---|
| September 30, 2020 | -15.17% |
| June 30, 2020 | -9.04% |
| March 31, 2020 | -7.45% |
| December 31, 2019 | -1.19% |
| September 30, 2019 | 1.30% |
| June 30, 2019 | 4.59% |
| March 31, 2019 | 4.31% |
| December 31, 2018 | 2.05% |
| September 30, 2018 | 7.91% |
| June 30, 2018 | -8.15% |
| March 31, 2018 | 9.88% |
| December 31, 2017 | -21.41% |
| September 30, 2017 | -2.97% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-102.6%
Minimum
Sep 2023
8.19%
Maximum
Mar 2023
-11.00%
Average
-6.89%
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 30.19% |
| Catalent Inc | -9.40% |
| NanoString Technologies Inc | -77.80% |
| Cytokinetics Inc | -8.19K% |
| Geron Corp | -18.22K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -19.54% |
| Return on Assets | -8.76% |
| Return on Invested Capital | -10.36% |
| Gross Profit Margin (Quarterly) | 57.26% |
| Operating Margin (Quarterly) | 11.04% |
| Return on Net Operating Assets | -9.54% |